Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
First Affiliated Hospital of Zhejiang University
Dana-Farber Cancer Institute
AvenCell Therapeutics, Inc.
City of Hope Medical Center
Fate Therapeutics
Center for International Blood and Marrow Transplant Research